KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Capital Employed: 2018-2025

Historic Return on Capital Employed for Aquestive Therapeutics (AQST) over the last 7 years, with Sep 2025 value amounting to -0.54%.

  • Aquestive Therapeutics' Return on Capital Employed fell 33.00% to -0.54% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.54%, marking a year-over-year decrease of 33.00%. This contributed to the annual value of -0.51% for FY2024, which is 12.00% down from last year.
  • Latest data reveals that Aquestive Therapeutics reported Return on Capital Employed of -0.54% as of Q3 2025, which was up 23.01% from -0.70% recorded in Q2 2025.
  • Over the past 5 years, Aquestive Therapeutics' Return on Capital Employed peaked at -0.14% during Q2 2024, and registered a low of -2.82% during Q4 2022.
  • In the last 3 years, Aquestive Therapeutics' Return on Capital Employed had a median value of -0.49% in 2025 and averaged -0.64%.
  • As far as peak fluctuations go, Aquestive Therapeutics' Return on Capital Employed slumped by 199bps in 2022, and later skyrocketed by 244bps in 2023.
  • Over the past 5 years, Aquestive Therapeutics' Return on Capital Employed (Quarterly) stood at -0.83% in 2021, then crashed by 199bps to -2.82% in 2022, then spiked by 244bps to -0.38% in 2023, then climbed by 2bps to -0.35% in 2024, then crashed by 33bps to -0.54% in 2025.
  • Its last three reported values are -0.54% in Q3 2025, -0.70% for Q2 2025, and -0.49% during Q1 2025.